Analytical Data
-
Gene name
C3orf49
- Application
-
Alternative Names
C3orf49Putative uncharacterized Protein C3orf49
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96BT1
-
Expression Region
1-292aa
-
AA Sequence
MAQPQLYLPEPFKIAYRKVGQCRRFQQLKKKNGSFKRKGIERWHRAVSTNLLKQNVLVPKEESSSDSDMGFHESQQNQKSNLKTKVKTAFGRMLSYKYRSKPACASQEGSTDHKEALLSNTQSLLPRIVKEFSSPKLFTAKMRKLSENATIQLDVVEAETEEITQGNTLLRARRTTKRLSVTSLPSGLQKGPYSPKKRPHFPALKKKKRGMENILRKSDLTVGKLQMQVDDLIETVTDKSMKLLAQRHAELQQCEFLGDEILQSSKQFQRISKRTMRKYKLKNMTTKGPGDS
-
Molecular Weight
59.9 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C3orf49, also known as Chromosome 3 Open Reading Frame 49, is a protein coded by a gene located on chromosome 3. Research into C3orf49 has gained attention due to its potential involvement in various biological processes and disease mechanisms, particularly in cancer and neurodegenerative disorders. Studies have indicated that this protein may play a role in regulating cell proliferation, apoptosis, and stress response pathways, which are critical for maintaining cellular homeostasis. The interest in C3orf49 is further fueled by its interaction with other proteins and its expression patterns observed in different tissues and during various developmental stages. Recent advancements in proteomics and genomics have paved the way for more in-depth investigations into the structure-function relationship of C3orf49 and its potential as a biomarker or therapeutic target. Investigating the recombinant expression of C3orf49 allows researchers to produce the protein in sufficient quantities for functional assays and structural studies. The findings from these studies could ultimately contribute to a better understanding of C3orf49's role in health and disease, paving the way for novel therapeutic interventions. Overall, the investigation of C3orf49 and its recombinant protein represents a promising frontier in biomedical research, offering insights that could lead to advancements in targeted therapies for complex diseases.
